Abstract:Genetic mutations have long been implicated in epilepsy, particularly in genes that encode ion channels and neurotransmitter receptors. Among some of those identified are voltage-gated sodium, potassium and calcium channels, and ligand-gated gamma-aminobutyric acid (GABA), neuronal nicotinic acetylcholine (CHRN), and glutamate receptors, making them key therapeutic targets. In this chapter we discuss the use of automated electrophysiological technologies to examine the impact of gene defects in two potassium channels associated with different epilepsy syndromes. The hKCNC1 gene encodes the voltage-gated potassium channel hKV3.1, and mutations in this gene cause progressive myoclonus epilepsy (PME) and ataxia due to a potassium channel mutation (MEAK). The hKCNT1 gene encodes the weakly voltage-dependent sodium-activated potassium channel hKCNT1, and mutations in this gene cause a wide spectrum of seizure disorders, including severe autosomal dominant sleep-related hypermotor epilepsy (ADSHE) and epilepsy of infancy with migrating focal seizures (EIMFS), both conditions associated with drug-resistance. Importantly, both of these potassium channels play vital roles in regulating neuronal excitability. Since its discovery in the late nineteen seventies, the patch-clamp technique has been regarded as the bench-mark technology for exploring ion channel characteristics. In more recent times, innovations in automated patch-clamp technologies, of which there are many, are enabling the study of ion channels with much greater productivity that manual systems are capable of. Here we describe aspects of Nanion NPC-16 Patchliner, examining the effects of temperature on stably and transiently transfected mammalian cells, the latter of which for most automated systems on the market is quite challenging. Remarkable breakthroughs in the development of other automated electrophysiological technologies, such as multielectrode arrays that support extracellular signal recordings, provide additional features to examine network activity in the area of ion channel research, particularly epilepsy. Both of these automated technologies enable the acquisition of consistent, robust, and reproducible data. Numerous systems have been developed with very similar capabilities, however, not all the systems on the market are adapted to work with primary cells, particularly neurons that can be problematic. This chapter also showcases methods that demonstrate the versatility of Nanion NPC-16 Patchliner and the Multi Channel Systems (MCS) multielectrode array (MEA) assay for acutely dissociated murine primary cortical neurons, enabling the study of potassium channel mutations implicated in severe refractory epilepsies.

Utilising Automated Electrophysiological Platforms in Epilepsy Research

Automated Tight Seal Electrophysiology for Assessing the Potential Herg Liability of Pharmaceutical Compounds

Application of High-Throughput Automated Patch-Clamp Electrophysiology to Study Voltage-Gated Ion Channel Function in Primary Cortical Cultures

High-throughput Electrophysiological Assays for Voltage Gated Ion Channels Using SyncroPatch 768PE.

The Need for Speed; Investigating Channelopathy-Associated Epilepsy Using High Throughput Electrophysiological Approaches

Using automated patch clamp electrophysiology platforms in ion channel drug discovery: an industry perspective

Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy

Novel screening techniques for ion channel targeting drugs

Single shot detection of alterations across multiple ionic currents from assimilation of cell membrane dynamics

Potassium channels and epilepsy

Progress in automating patch clamp cellular physiology

Advances in the automation of whole-cell patch clamp technology

High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity

Optimizing clinical interpretability of functional evidence in epilepsy-related ion channel variants

Preface: Special issue: "Ion channels and genetic epilepsy"

A Comparison of the Performance and Application Differences Between Manual and Automated Patch-Clamp Techniques.

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties

Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification

Single shot diagnosis of ion channel dysfunction from assimilation of cell membrane dynamics